Global Imatinib Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Imatinib Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Capsules
1.2.3 Tablets
1.3 Market Segment by Application
1.3.1 Global Imatinib Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Imatinib Drugs Market Size (2017-2028)
2.1.1 Global Imatinib Drugs Revenue (2017-2028)
2.1.2 Global Imatinib Drugs Sales (2017-2028)
2.2 Global Imatinib Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Imatinib Drugs Sales by Regions (2017-2022)
2.2.2 Global Imatinib Drugs Revenue by Regions (2017-2022)
2.3 Global Imatinib Drugs Market Size Forecast by Region
2.3.1 Global Imatinib Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Imatinib Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Imatinib Drugs Regions (Countries) Ranking by Market Size
2.5 Imatinib Drugs Market Dynamics
2.5.1 Imatinib Drugs Market Trends
2.5.2 Imatinib Drugs Market Drivers
2.5.3 Imatinib Drugs Market Challenges
2.5.4 Imatinib Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Imatinib Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Imatinib Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Imatinib Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Imatinib Drugs Sales in 2021
3.2 Global Top Manufacturers Imatinib Drugs by Revenue
3.2.1 Global Imatinib Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Imatinib Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Imatinib Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Imatinib Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Drugs as of 2021)
3.4 Global Imatinib Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Imatinib Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Imatinib Drugs Market
3.7 Key Manufacturers Imatinib Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Imatinib Drugs Market Size by Type
4.1 Global Imatinib Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Imatinib Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Imatinib Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Imatinib Drugs Price by Type (2017-2022)
4.2 Global Imatinib Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Imatinib Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Imatinib Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Imatinib Drugs Price Forecast by Type (2023-2028)
5 Global Imatinib Drugs Market Size by Application
5.1 Global Imatinib Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Imatinib Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Imatinib Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Imatinib Drugs Price by Application (2017-2022)
5.2 Global Imatinib Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Imatinib Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Imatinib Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Imatinib Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Imatinib Drugs Sales Breakdown by Company
6.1.1 North America Imatinib Drugs Sales by Company (2017-2022)
6.1.2 North America Imatinib Drugs Revenue by Company (2017-2022)
6.2 North America Imatinib Drugs Market Size by Type
6.2.1 North America Imatinib Drugs Sales by Type (2017-2028)
6.2.2 North America Imatinib Drugs Revenue by Type (2017-2028)
6.3 North America Imatinib Drugs Market Size by Application
6.3.1 North America Imatinib Drugs Sales by Application (2017-2028)
6.3.2 North America Imatinib Drugs Revenue by Application (2017-2028)
6.4 North America Imatinib Drugs Market Size by Country
6.4.1 North America Imatinib Drugs Sales by Country (2017-2028)
6.4.2 North America Imatinib Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Imatinib Drugs Sales Breakdown by Company
7.1.1 Europe Imatinib Drugs Sales by Company (2017-2022)
7.1.2 Europe Imatinib Drugs Revenue by Company (2017-2022)
7.2 Europe Imatinib Drugs Market Size by Type
7.2.1 Europe Imatinib Drugs Sales by Type (2017-2028)
7.2.2 Europe Imatinib Drugs Revenue by Type (2017-2028)
7.3 Europe Imatinib Drugs Market Size by Application
7.3.1 Europe Imatinib Drugs Sales by Application (2017-2028)
7.3.2 Europe Imatinib Drugs Revenue by Application (2017-2028)
7.4 Europe Imatinib Drugs Market Size by Country
7.4.1 Europe Imatinib Drugs Sales by Country (2017-2028)
7.4.2 Europe Imatinib Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Imatinib Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Imatinib Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Imatinib Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Imatinib Drugs Market Size by Type
8.2.1 Asia Pacific Imatinib Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Imatinib Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Imatinib Drugs Market Size by Application
8.3.1 Asia Pacific Imatinib Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Imatinib Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Imatinib Drugs Market Size by Region
8.4.1 Asia Pacific Imatinib Drugs Sales by Region
8.4.2 Asia Pacific Imatinib Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Imatinib Drugs Sales Breakdown by Company
9.1.1 Latin America Imatinib Drugs Sales by Company (2017-2022)
9.1.2 Latin America Imatinib Drugs Revenue by Company (2017-2022)
9.2 Latin America Imatinib Drugs Market Size by Type
9.2.1 Latin America Imatinib Drugs Sales by Type (2017-2028)
9.2.2 Latin America Imatinib Drugs Revenue by Type (2017-2028)
9.3 Latin America Imatinib Drugs Market Size by Application
9.3.1 Latin America Imatinib Drugs Sales by Application (2017-2028)
9.3.2 Latin America Imatinib Drugs Revenue by Application (2017-2028)
9.4 Latin America Imatinib Drugs Market Size by Country
9.4.1 Latin America Imatinib Drugs Sales by Country (2017-2028)
9.4.2 Latin America Imatinib Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Imatinib Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Imatinib Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Imatinib Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Imatinib Drugs Market Size by Type
10.2.1 Middle East and Africa Imatinib Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Imatinib Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Imatinib Drugs Market Size by Application
10.3.1 Middle East and Africa Imatinib Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Imatinib Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Imatinib Drugs Market Size by Country
10.4.1 Middle East and Africa Imatinib Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Imatinib Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Overview
11.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Apotex Inc. Imatinib Drugs Products and Services
11.1.5 Apotex Inc. Imatinib Drugs SWOT Analysis
11.1.6 Apotex Inc. Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Novartis Imatinib Drugs Products and Services
11.2.5 Novartis Imatinib Drugs SWOT Analysis
11.2.6 Novartis Recent Developments
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Corporation Information
11.3.2 Sanofi S.A. Overview
11.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sanofi S.A. Imatinib Drugs Products and Services
11.3.5 Sanofi S.A. Imatinib Drugs SWOT Analysis
11.3.6 Sanofi S.A. Recent Developments
11.4 Cipla Inc.
11.4.1 Cipla Inc. Corporation Information
11.4.2 Cipla Inc. Overview
11.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Cipla Inc. Imatinib Drugs Products and Services
11.4.5 Cipla Inc. Imatinib Drugs SWOT Analysis
11.4.6 Cipla Inc. Recent Developments
11.5 Mylan Pharms Inc.
11.5.1 Mylan Pharms Inc. Corporation Information
11.5.2 Mylan Pharms Inc. Overview
11.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Mylan Pharms Inc. Imatinib Drugs Products and Services
11.5.5 Mylan Pharms Inc. Imatinib Drugs SWOT Analysis
11.5.6 Mylan Pharms Inc. Recent Developments
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
11.6.2 Glenmark Pharmaceuticals Ltd. Overview
11.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Products and Services
11.6.5 Glenmark Pharmaceuticals Ltd. Imatinib Drugs SWOT Analysis
11.6.6 Glenmark Pharmaceuticals Ltd. Recent Developments
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Corporation Information
11.7.2 Sun Pharmaceuticals Overview
11.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Sun Pharmaceuticals Imatinib Drugs Products and Services
11.7.5 Sun Pharmaceuticals Imatinib Drugs SWOT Analysis
11.7.6 Sun Pharmaceuticals Recent Developments
11.8 Actavis Generics
11.8.1 Actavis Generics Corporation Information
11.8.2 Actavis Generics Overview
11.8.3 Actavis Generics Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Actavis Generics Imatinib Drugs Products and Services
11.8.5 Actavis Generics Imatinib Drugs SWOT Analysis
11.8.6 Actavis Generics Recent Developments
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Corporation Information
11.9.2 Dr. Reddy's Laboratories Overview
11.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Dr. Reddy's Laboratories Imatinib Drugs Products and Services
11.9.5 Dr. Reddy's Laboratories Imatinib Drugs SWOT Analysis
11.9.6 Dr. Reddy's Laboratories Recent Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.10.2 Teva Pharmaceutical Industries Ltd. Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Products and Services
11.10.5 Teva Pharmaceutical Industries Ltd. Imatinib Drugs SWOT Analysis
11.10.6 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Imatinib Drugs Value Chain Analysis
12.2 Imatinib Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Imatinib Drugs Production Mode & Process
12.4 Imatinib Drugs Sales and Marketing
12.4.1 Imatinib Drugs Sales Channels
12.4.2 Imatinib Drugs Distributors
12.5 Imatinib Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Imatinib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Capsules
Table 3. Major Manufacturers of Tablets
Table 4. Global Imatinib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Imatinib Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Imatinib Drugs Sales by Region (2017-2022) & (K MT)
Table 7. Global Imatinib Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Imatinib Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Imatinib Drugs Revenue Market Share by Region (2017-2022)
Table 10. Global Imatinib Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 11. Global Imatinib Drugs Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Imatinib Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Imatinib Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Imatinib Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Imatinib Drugs Market Trends
Table 16. Imatinib Drugs Market Drivers
Table 17. Imatinib Drugs Market Challenges
Table 18. Imatinib Drugs Market Restraints
Table 19. Global Imatinib Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 20. Global Imatinib Drugs Sales Share by Manufacturers (2017-2022)
Table 21. Global Imatinib Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Imatinib Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 23. Imatinib Drugs Revenue Share by Manufacturers (2017-2022)
Table 24. Global Imatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Drugs as of 2021)
Table 26. Key Manufacturers Imatinib Drugs Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 27. Key Manufacturers Imatinib Drugs Plants/Factories Distribution
Table 28. Key Manufacturers Imatinib Drugs Area Served
Table 29. Date of Key Manufacturers Enter into Imatinib Drugs Market
Table 30. Key Manufacturers Imatinib Drugs Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Imatinib Drugs Sales (K MT) by Type (2017-2022)
Table 33. Global Imatinib Drugs Sales Share by Type (2017-2022)
Table 34. Global Imatinib Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Imatinib Drugs Price (K MT) by Type (2017-2022)
Table 36. Global Imatinib Drugs Sales (K MT) by Type (2023-2028)
Table 37. Global Imatinib Drugs Sales Share by Type (2023-2028)
Table 38. Global Imatinib Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Imatinib Drugs Revenue Share by Type (2023-2028)
Table 40. Global Imatinib Drugs Price (K MT) by Type (2023-2028)
Table 41. Global Imatinib Drugs Sales (K MT) by Application (2017-2022)
Table 42. Global Imatinib Drugs Sales Share by Application (2017-2022)
Table 43. Global Imatinib Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Imatinib Drugs Price (K MT) by Application (2017-2022)
Table 45. Global Imatinib Drugs Sales (K MT) by Application (2023-2028)
Table 46. Global Imatinib Drugs Sales Share by Application (2023-2028)
Table 47. Global Imatinib Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Imatinib Drugs Revenue Share by Application (2023-2028)
Table 49. Global Imatinib Drugs Price (K MT) by Application (2023-2028)
Table 50. North America Imatinib Drugs Sales by Company (2017-2022) & (K MT)
Table 51. North America Imatinib Drugs Sales Market Share by Company (2017-2022)
Table 52. North America Imatinib Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Imatinib Drugs Revenue Market Share by Company (2017-2022)
Table 54. North America Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 55. North America Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 56. North America Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 59. North America Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 60. North America Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 63. North America Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 64. North America Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Imatinib Drugs Sales by Company (2017-2022) & (K MT)
Table 67. Europe Imatinib Drugs Sales Market Share by Company (2017-2022)
Table 68. Europe Imatinib Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Imatinib Drugs Revenue Market Share by Company (2017-2022)
Table 70. Europe Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 71. Europe Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 72. Europe Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 75. Europe Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 76. Europe Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 79. Europe Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 80. Europe Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Imatinib Drugs Sales by Company (2017-2022) & (K MT)
Table 83. Asia Pacific Imatinib Drugs Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Imatinib Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Imatinib Drugs Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 87. Asia Pacific Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 88. Asia Pacific Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 91. Asia Pacific Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 92. Asia Pacific Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Imatinib Drugs Sales by Region (2017-2022) & (K MT)
Table 95. Asia Pacific Imatinib Drugs Sales by Region (2023-2028) & (K MT)
Table 96. Asia Pacific Imatinib Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Imatinib Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Imatinib Drugs Sales by Company (2017-2022) & (K MT)
Table 99. Latin America Imatinib Drugs Sales Market Share by Company (2017-2022)
Table 100. Latin America Imatinib Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Imatinib Drugs Revenue Market Share by Company (2017-2022)
Table 102. Latin America Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 103. Latin America Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 104. Latin America Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 107. Latin America Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 108. Latin America Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 111. Latin America Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 112. Latin America Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Imatinib Drugs Sales by Company (2017-2022) & (K MT)
Table 115. Middle East and Africa Imatinib Drugs Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Imatinib Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Imatinib Drugs Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 119. Middle East and Africa Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 120. Middle East and Africa Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 123. Middle East and Africa Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 124. Middle East and Africa Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 127. Middle East and Africa Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 128. Middle East and Africa Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 130. Apotex Inc. Corporation Information
Table 131. Apotex Inc. Description and Overview
Table 132. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 133. Apotex Inc. Imatinib Drugs Product and Services
Table 134. Apotex Inc. Imatinib Drugs SWOT Analysis
Table 135. Apotex Inc. Recent Developments
Table 136. Novartis Corporation Information
Table 137. Novartis Description and Overview
Table 138. Novartis Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 139. Novartis Imatinib Drugs Product and Services
Table 140. Novartis Imatinib Drugs SWOT Analysis
Table 141. Novartis Recent Developments
Table 142. Sanofi S.A. Corporation Information
Table 143. Sanofi S.A. Description and Overview
Table 144. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 145. Sanofi S.A. Imatinib Drugs Product and Services
Table 146. Sanofi S.A. Imatinib Drugs SWOT Analysis
Table 147. Sanofi S.A. Recent Developments
Table 148. Cipla Inc. Corporation Information
Table 149. Cipla Inc. Description and Overview
Table 150. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 151. Cipla Inc. Imatinib Drugs Product and Services
Table 152. Cipla Inc. Imatinib Drugs SWOT Analysis
Table 153. Cipla Inc. Recent Developments
Table 154. Mylan Pharms Inc. Corporation Information
Table 155. Mylan Pharms Inc. Description and Overview
Table 156. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 157. Mylan Pharms Inc. Imatinib Drugs Product and Services
Table 158. Mylan Pharms Inc. Imatinib Drugs SWOT Analysis
Table 159. Mylan Pharms Inc. Recent Developments
Table 160. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 161. Glenmark Pharmaceuticals Ltd. Description and Overview
Table 162. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 163. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product and Services
Table 164. Glenmark Pharmaceuticals Ltd. Imatinib Drugs SWOT Analysis
Table 165. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 166. Sun Pharmaceuticals Corporation Information
Table 167. Sun Pharmaceuticals Description and Overview
Table 168. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 169. Sun Pharmaceuticals Imatinib Drugs Product and Services
Table 170. Sun Pharmaceuticals Imatinib Drugs SWOT Analysis
Table 171. Sun Pharmaceuticals Recent Developments
Table 172. Actavis Generics Corporation Information
Table 173. Actavis Generics Description and Overview
Table 174. Actavis Generics Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 175. Actavis Generics Imatinib Drugs Product and Services
Table 176. Actavis Generics Imatinib Drugs SWOT Analysis
Table 177. Actavis Generics Recent Developments
Table 178. Dr. Reddy's Laboratories Corporation Information
Table 179. Dr. Reddy's Laboratories Description and Overview
Table 180. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 181. Dr. Reddy's Laboratories Imatinib Drugs Product and Services
Table 182. Dr. Reddy's Laboratories Imatinib Drugs SWOT Analysis
Table 183. Dr. Reddy's Laboratories Recent Developments
Table 184. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 185. Teva Pharmaceutical Industries Ltd. Description and Overview
Table 186. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 187. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product and Services
Table 188. Teva Pharmaceutical Industries Ltd. Imatinib Drugs SWOT Analysis
Table 189. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Imatinib Drugs Distributors List
Table 193. Imatinib Drugs Customers List
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of FiguresFigure 1. Imatinib Drugs Product Picture
Figure 2. Global Imatinib Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Capsules Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Imatinib Drugs Sales Market Share by Application in 2021 & 2028
Figure 6. Hospitals Use Case
Figure 7. Drug Stores Use Case
Figure 8. Others Use Case
Figure 9. Imatinib Drugs Report Years Considered
Figure 10. Global Imatinib Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Imatinib Drugs Market Size 2017-2028 (US$ Million)
Figure 12. Global Imatinib Drugs Sales (2017-2022) & (K MT)
Figure 13. Global Imatinib Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Imatinib Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Imatinib Drugs Sales Market Share by Region in 2021
Figure 16. Global Imatinib Drugs Revenue Market Share by Region in 2017 VS 2021
Figure 17. Global Imatinib Drugs Sales Share by Manufacturers in 2021
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Drugs Sales in 2021
Figure 19. Imatinib Drugs Revenue Share by Manufacturers in 2021
Figure 20. Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Imatinib Drugs Revenue Share by Type (2017-2022)
Figure 22. Global Imatinib Drugs Revenue Growth Rate by Type in 2017 & 2021
Figure 23. Global Imatinib Drugs Revenue Share by Application (2017-2022)
Figure 24. Global Imatinib Drugs Revenue Growth Rate by Application in 2017 & 2021
Figure 25. North America Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 26. North America Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 27. North America Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 28. North America Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 29. North America Imatinib Drugs Sales Share by Country (2017-2028)
Figure 30. North America Imatinib Drugs Revenue Share by Country (2017-2028)
Figure 31. U.S. Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 32. Canada Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 33. Europe Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 34. Europe Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Europe Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 36. Europe Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Europe Imatinib Drugs Sales Share by Country (2017-2028)
Figure 38. Europe Imatinib Drugs Revenue Share by Country (2017-2028)
Figure 39. Germany Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. France Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. U.K. Imatinib Drugs Revenue (2017-2028) & (US$ Mi